drugset / Trial / NCT04737408

Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)

NCT04737408

Phase 3 Unknown 120 enrolled Bjarne Linde Noergaard
RandomizedParallel-groupOpen-labelPrevention

Summary

The FLOW-PROMOTE Study is an investigator-initiated, Danish multicenter study of patients with stable chest pain investigating whether lipid lowering is associated with recovery of impaired coronary flow as assessed by CT derived fractional flow reserve (FFRCT).

Timeline

Start
2020-05-13
Primary completion
2023-08
Completion
2023-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 40 mg